Literature DB >> 8473083

Diagnostic and therapeutic strategies of pyogenic liver abscess.

H Shimada1, S Ohta, M Maehara, K Katayama, M Note, G Nakagawara.   

Abstract

The infectious routes and etiologies of 26 cases with pyogenic liver abscess were portal spread in one, hematogenous in three, biliary in 12, transarterial embolization (TAE) in three, posthepatectomy in one and cryptogenic in five cases. Portal and hematogenous cases tend to show solitary and cystic pattern on echogram, and the majority of the bacteria detected was Klebsiella. While most biliary cases show multiple and cystic with tumor pattern on echogram, and an unhomogeneous low density in CT feature, anaerobic bacteria and candida were isolated only from the biliary or TAE cases. Most cases could be cured completely by the various kinds of abscess drainage, but two TAE cases with PTAD (percutaneous transhepatic abscess drainage) and two biliary cases with PTBD (PT-biliary drainage) and PTAD died due to a delay in establishing a diagnosis and to the severity of the condition. An early diagnosis followed by PTAD or PTBD were thought to be of prime importance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473083

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  3 in total

1.  Changing clinical spectrum of liver abscess.

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  1995-02       Impact factor: 2.401

2.  Causative agents of liver abscess in Thai hepatitis B carriers.

Authors:  Viroj Wiwanitkit; Jamsai Suwansaksri; Nattakarn Suwansaksri
Journal:  MedGenMed       Date:  2004-03-09

3.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.